Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Chloroquine Alone vs. Concurrent Chloroquine and Primaquine for Uncomplicated Vivax Malaria
NCT02691910Phase 3Completed
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of chloroquine in Plasmodium vivax malaria (2 arms), sponsored by Fundação Oswaldo Cruz. Primary endpoints: Early treatment failure at 3 days and Schizontocidal Efficacy of Chloroquine at 28 days. Started Aug 2014; status: completed.
02
Drugs
chloroquine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT02691910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691910.